Bullish
$AMRN lol if you are just waking up... Epanova strength trial stopped early due to "unlikelihood to demonstrate patient benefit" Amarin launched an advertisement/education campaign truetoyourheart.com/ CaPre trial trilogy 1 is statistically insignificant
  • 20
  • 1